CN Patent

CN1874774A — 包含胰岛素致敏剂、胰岛素促分泌素和聚氧乙烯脱水山梨醇脂肪酸酯的固体制剂

Assigned to Takeda Pharmaceutical Co Ltd · Expires 2006-12-06 · 19y expired

What this patent protects

本发明涉及用作糖尿病治疗剂等并具有优异的胰岛素致敏剂和胰岛素促分泌素的溶出性能的固体制剂，其包含胰岛素致敏剂、胰岛素促分泌素和聚氧乙烯脱水山梨糖醇脂肪酸酯。

USPTO Abstract

本发明涉及用作糖尿病治疗剂等并具有优异的胰岛素致敏剂和胰岛素促分泌素的溶出性能的固体制剂，其包含胰岛素致敏剂、胰岛素促分泌素和聚氧乙烯脱水山梨糖醇脂肪酸酯。

Drugs covered by this patent

Patent Metadata

Patent number
CN1874774A
Jurisdiction
CN
Classification
—
Expires
2006-12-06
Drug substance claim
No
Drug product claim
No
Assignee
Takeda Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.